Dr. Mahavir Agarwal is a Psychiatrist and Scientist in the Schizophrenia Division at the Centre for Addiction at Mental Health (CAMH), Toronto and an Associate Professor in the Department of Psychiatry at the University of Toronto. He is also the Medical Head for Clinical Research in the Schizophrenia Division and co-leads the Metabolic Clinic and the Clozapine Clinic at CAMH.
Dr. Agarwal’s research interest lies in understanding the mechanisms underlying metabolic and cognitive dysfunction in mental illness with specific focus on insulin signaling in the brain. He also runs clinical trials to evaluate the efficacy of new treatments for these abnormalities. He has won several international research awards and his research program has been funded by federal, provincial, and local grant agencies.
View Dr. Agarwal's publications here: